Close

Beyond Air and Goetz Healthcare Partner to Commercialise LungFit PH in Asia-Pacific

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...

The Three Top Benefits of Opting for an Innovative Healthcare Practice

An innovative healthcare practice offers improved patient care through...

Remote Patient Monitoring: A Cost-Effective Solution for Patients and Health Facilities

Remote patient monitoring services are reshaping the healthcare landscape,...

Beyond Air has entered into an agreement with Goetz Healthcare to facilitate the commercialisation of its LungFit PH device in specific countries within the Asia-Pacific region.

According to the agreement, Goetz Healthcare will make a milestone payment to Beyond Air once the LungFit PH obtains CE mark certification in the European Union. This CE mark certification not only signifies compliance with European standards but also serves as a route for potential approval in specific Asia-Pacific nations.

Through this partnership, healthcare institutions in a diverse range of countries, including Australia, New Zealand, Thailand, Philippines, Taiwan, Hong Kong, Malaysia, Pakistan, Singapore, and Vietnam will have the opportunity to leverage the benefits of the LungFit PH device.

LungFit PH, a cylinder-free phasic flow generator and delivery system with FDA premarket approval, presents a transformative solution for healthcare facilities in multiple countries. This innovative device is compatible with ventilators and can efficiently generate nitric oxide (NO) from ambient air on demand, enabling precise delivery to the lungs with concentrations ranging from 1 ppm to 80 ppm.

In the hospital setting, LungFit PH holds the potential to replace cumbersome high-pressure NO cylinders, offering a range of significant advantages. These include a substantial reduction in inventory and storage requirements, enhanced safety through the elimination of NO2 purging procedures, and a host of other benefits.

Latest stories

Related stories

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...

The Three Top Benefits of Opting for an Innovative Healthcare Practice

An innovative healthcare practice offers improved patient care through...

Remote Patient Monitoring: A Cost-Effective Solution for Patients and Health Facilities

Remote patient monitoring services are reshaping the healthcare landscape,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back